Scott Robarge utilizes his expertise in recruiting to serve as the founder and operator of Another8, a recruiting firm that works with developing technology companies. In addition to his responsibilities with Another8, Scott Robarge supports the research and advocacy efforts of the Alzheimer’s Association.
The Alzheimer’s Association recently issued a press release to announce that it has expanded its funding commitment and partnership with other research support organizations to advance a global initiative called Biomarkers Across Neurodegenerative Diseases (BAND), which will investigate the corresponding features of different brain-deteriorating diseases. During the new funding cycle, BAND researchers will collectively receive almost $2 million in research grant awards for projects that compare existing research on the clinical symptoms and biology of diseases like Alzheimer's and Parkinson's.
This second round of BAND funding is the result of collaboration between the Alzheimer's Association, the Weston Brain Institute in Canada, Alzheimer's Research UK, and the Michael J. Fox Foundation for Parkinson's Research in the U.S. According to the Alzheimer’s Association’s press release, the organizations hope that studying the overlap between brain-deteriorating diseases will lead to treatments that are effective for multiple conditions.